Advanced glycation end products (AGE)-modified proteins and their potential relevance to atherosclerosis

Trends in Cardiovascular Medicine

Volumn 6, Issue 5, 1996, Pages 163-168

  Horiuchi, Seikoh ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; MEMBRANE PROTEIN; SCAVENGER;

ANIMAL CELL; ATHEROSCLEROSIS; CHO CELL; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; INCUBATION TIME; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN GLYCOSYLATION; PROTEIN INTERACTION; PROTEIN MODIFICATION; REVIEW;

EID: 0030200678     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/1050-1738(96)00050-3     Document Type: Review

References (50)

1. Acton SL, Scherer PE, Lodish HF, Krieger M Expression cloning of SR-BI, a CD36-related Class B scavenger receptor. J Biol Chem. 269:1994;21,003-21,009.
2. ε-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. J Biol Chem. 261:1986;4889-4894.
3. Araki N, Ueno N, Chacrabarti B, Morino Y, Horiuchi S Immunochemical evidence for the presence of advanced glycation end products in human lens proteins and its positive correlation with aging. J Biol Chem. 267:1992;10,211-10,214.
4. Araki N, Higashi T, Mori Tet al. Macrophage scavenger receptor mediates the endocytic uptake of advanced glycation end-products of the Maillard reaction. Eur J Biochem. 230:1995;408-415.
5. Ashkenas J, Penman M, Vasile E, Acton S, Freeman M, Krieger M Structures and high and low affinity ligand binding properties of murine type I and type II macrophage scavenger receptors. J Lipid Res. 34:1993;983-1000.
6. Brett J, Schmidt AM, Yan SDet al. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol. 143:1993;1699-1712.
7. Brown MS, Goldstein JL Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem. 52:1983;223-261.
8. Bucala R, Makita Z, Koschinsky T, Cerami A, Vlassara H Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc Natl Acad Sci USA. 90:1993;6434-6438.
9. Bucala R, Cerami A, Vlassara H Advanced glycosylation end products in diabetic complications. Diabetes Rev. 3:1995;258-268.
10. Endermann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem. 268:1993;11,811-11,816.
11. Freeman M, Ekkel Y, Rohrer Let al. Expression of type I and type II bovine scavenger receptors in Chinese hamster ovary cells: lipid droplet accumulation and nonreciprocal cross competition by acetylated and oxidized low density lipoprotein. Proc Natl Acad Sci USA. 88:1991;4931-4935.
12. Goldstein JL, Ho YK, Basu SK, Brown MS Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA. 76:1979;333-337.
13. Hayase F, Nagaraj RH, Miyata S, Njoroge FG, Monnier VM Aging of proteins: immunological detection of a glucose derived pyrrole formed during Maillard reaction in vivo. J Biol Chem. 263:1989;3758-3764.
14. Horiuchi S, Takata K, Maeda H, Morino Y Scavenger function of sinusoidal liver cells: acetylated low-density lipoprotein is endocytosed via a route distinct from formaldehyde-treated serum albumin. J Biol Chem. 260:1985;53-56.
15. Horiuchi S, Takata K, Morino Y Characterization of a membrane associated receptor from rat sinusoidal liver cells that binds formaldehyde-treated serum albumin. J Biol Chem. 260:1985;475-481.
16. Horiuchi S, Murakami M, Takata K, Morino Y Scavenger receptor for aldehyde-modified proteins. J Biol Chem. 261:1986;4962-4966.
17. Horiuchi S, Araki N, Morino Y Immunochemical approach to characterize advanced glycation end products of Maillard reaction: evidence for the presence of a common structure. J Biol Chem. 266:1991;7329-7332.
18. Ienaga K, Nakamura K, Hochi Tet al. Crosslines, fluorophoes in the AGE-related cross-linked proteins. Contrib Nephrol. 112:1995;42-51.
19. Kirstein M, Aston C, Hintz R, Vlassara H Receptor-specific induction of insulin-like growth factor I (IGF-I) in human monocytes by advanced glycosylation end product-modified proteins. J Clin Invest. 90:1992;439-446.
20. Kodama T, Freeman M, Rohrer L, Zabrecky J, Matudaira P, Krieger M Type I macrophage scavenger receptor contains α-helical and collagen-like coiled coils. Nature. 343:1990;531-535.
21. Krieger M, Herz J Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu Rev Biochem. 63:1994;601-637.
22. Kume S, Takeya M, Mori Tet al. Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta using a novel specific monoclonal antibody. Am J Pathol. 147:1995;654-667.
23. Maillard LC Action des acides amines sur les sucres: formation des melanoidines par voie methodique. C R Acad Sci III. 154:1912;66-68.
24. Makita Z, Radoff S, Rayfield EJet al. Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med. 325:1991;836-842.
25. Makita Z, Vlassara H, Cerami A, Bucala R Immunochemical detection of advanced glycosylation end products in vivo. J Biol Chem. 267:1992;5133-5138.
26. Matsumoto A, Naito M, Itakura Het al. Human macrophage scavenger receptors, primary structure, expression, and localization in atherosclerotic lesions. Proc Natl Acad Sci USA. 87:1990;9133-9137.
27. Mego JL, Bertini F, McQueen JD The use of formaldehyde-treated 131-I-albumin in the study of digestive vacuoles and some properties of these particles from mouse liver. J Cell Biol. 32:1967;699-707.
28. 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest. 92:1993;1243-1252.
29. Naito M, Suzuki H, Mori T, Matsumoto A, Kodama T, Takahashi K Coexpression of type I and type II human macrophage scavenger receptors in macrophages of various organs and foam cells in atherosclerotic lesions. Am J Pathol. 141:1992;591-599.
30. Nakamura Y, Horii Y, Nishino Tet al. Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus. Am J Pathol. 143:1993;1649-1656.
31. Nakayama H, Mitsuhashi T, Kuwajima Set al. Immunochemical detection of advanced glycation end products in lens crystallins from streptozotocin induced diabetes rat. Diabetes. 42:1993;345-350.
32. Neeper M, Schmidt AM, Brett J Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem. 267:1992;14,998-15,004.
33. Pearson AM, Rich A, Krieger M Polynucleotide binding to macrophage scavenger receptors depends on the formation of basequartet-stabilized four-stranded helices. J Biol Chem. 268:1993;3546-3554.
34. ε-(carboxymethyl) lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry. 34:1995;10,872-10,878.
35. Ritthaler U, Deng Y, Zhang Yet al. Expression of receptors for advanced glycation end products in peripheral occlusive vascular disease. Am J Pathol. 146:1995;688-693.
36. Schmidt AM, Vianna M, Gerlach M et al. Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J Biol Chem. 267:1992;14,987-14,997.
37. Schmidt AM, Hori O, Brett J, Yan SD, Wautier J-L, Stern D Cellular receptors for advanced glycation end products: implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb. 14:1994;1521-1528.
38. Sell DR, Monnier VM End-stage renal disease and diabetes and catalyze the formation of a pentose-derived crosslink from aging human collagen. J Clin Invest. 85:1990;380-384.
39. Skolnik EY, Yang Z, Makita Zet al. Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodeling and diabetic nephropathy. J Exp Med. 174:1991;931-939.
40. Stanton LW, White RT, Bryant CM, Protter AA, Endelmann G A macrophage Fc receptor for IgG is also a receptor for oxidized low density lipoprotein. J Biol Chem. 267:1992;22,446-22,451.
41. Suzuki H, Kurihara Y, Wada Y, et al.: 1995. Establishment and analysis of scavenger receptor knockout mice. Circulation (Suppl) 92:I-428.
42. Takata K, Horiuchi S, Araki N, Shiga M, Saitoh M, Morino Y Endocytic uptake of non-enzymatically glycosylated proteins is mediated by a scavenger receptor for aldehyde-modified proteins. J Biol Chem. 263:1988;14,819-14,825.
43. Takata K, Horiuchi S, Morino Y Scavenger receptor-mediated recognition of maleyllated albumin and its relation to subsequent endocytic degradation. Biochim Biophys Acta. 984:1989;273-280.
44. Vlassara H, Brownlee M, Cerami A High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules. Proc Natl Acad Sci USA. 82:1985;5588-5592.
45. Vlassara H, Brownlee M, Cerami A Novel macrophage receptor for glucose-modified proteins is distinct from previously described scavenger receptors. J Exp Med. 164:1986;1301-1309.
46. Vlassara H, Brownlee M, Manogue KR, Cerami A Cachectin/TNF and IL-1 induced by glucose modified proteins. Science. 240:1988;156-157.
47. Vlassara H, Bucala R, Striker L Biology of disease: pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest. 70:1994;138-151.
48. Yamada K, Nakano H, Nakayama Met al. Immunohistochemical study of human AGE in chronic renal failure. Clin Nephrol. 42:1994;354-361.
49. Yang Z, Makita Z, Horii Yet al. Two novel rat liver membrane proteins that bind advanced glycation end products: relationship to macrophage receptor for glucose-modified proteins. J Exp Med. 174:1991;515-524.
50. Yui S, Sasaki T, Araki N, Horiuchi S, Yamasaki M Induction of macrophage growth by advanced glycation end products of the Maillard reaction. J Immunol. 152:1994;1943-1949.